Vafseo Європейський Союз - ісландська - EMA (European Medicines Agency)

vafseo

akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - sýklalyf - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

Ranexa (previously Latixa) Європейський Союз - ісландська - EMA (European Medicines Agency)

ranexa (previously latixa)

menarini international operations luxembourg s.a. (miol) - ranolazin - angina pectoris - hjarta meðferð - ranexa er ætlað sem viðbótarmeðferð til að meðhöndla einkenni sjúklinga með stöðugan hjartaöng sem eru ófullnægjandi stjórnandi eða óþol fyrir fyrstu meðferð gegn hjartaöng (svo sem beta-blokkar og / eða kalsíumgangar).

Ozawade Європейський Союз - ісландська - EMA (European Medicines Agency)

ozawade

bioprojet pharma - pitolisant - sleep apnea, obstructive - Önnur lyf í taugakerfinu - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).

Fontex Dreifitafla 20 mg Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

fontex dreifitafla 20 mg

eli lilly danmark a/s - fluoxetinum hýdróklóríð - dreifitafla - 20 mg